Event Gaps: Claude Sonnet 5.5's picks for 2026-10-05
Claude Sonnet 5.5 picked CHRW, LW, PENG, RXO, INTC for a 1-day horizon. Intraday alpha vs SPY: +0.37%. Picks with positive alpha: 20%.
| Experiment | Event Gaps |
|---|---|
| Model | Claude Sonnet 5.5 |
| Prompt version | event-gap-v12 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-05 |
| Measured to | 2026-10-06 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | +0.37% |
| Picks with positive alpha | 20% |
| Benchmark return | +1.11% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | CHRW | -3.86% | -3.86% | 55% | -4.97% | No | |
| 2 | LW | +11.89% | +11.89% | 52% | +10.77% | Yes | |
| 3 | PENG | +0.27% | +0.27% | 50% | -0.84% | No | |
| 4 | RXO | -1.49% | -1.49% | 48% | -2.61% | No | |
| 5 | INTC | -0.60% | +0.60% | 45% | -0.51% | No |
The model's market view
Cautious, event-driven tape. A weak September payrolls print, Treasury yields near multiyear highs and strategist warnings about an AI-capex reality check argue against a strong beta chase. This book is mostly overreaction and earnings-anticipation trades: one acquirer sold off hard on dilution, two names with confirmed pre-earnings catalysts inside or just after the window, and one crowded momentum name fading on an unconfirmed headline. Direct quotes were found for only some picks, so reference prices are labelled with their dates and sources. All three liquidity and size screens were checked from the sources cited; the INTC market cap and average dollar volume are derived (shares times price, volume times price) and approximate.
Why each pick
CHRW
Observed fact: C.H. Robinson announced on Oct 5 that it will buy RXO for about $5.8B in cash and stock, and CHRW fell roughly 8% to 14% intraday on dilution, new debt, a buyback pause and integration risk. The latest quote I could find was about $148 (a Robinhood intraday snapshot whose exact timestamp I could not confirm; an earlier Yahoo reading showed about $157.72). Thesis: an acquirer discount of this size, for a deal with about $300M of targeted synergies and a Buy reiteration from Wells Fargo, looks overdone. A partial rebound is likely as merger-arbitrage shorting and forced selling fade. Expected move: +3% from the current level. Risks: dilution worries could persist and the stock could keep sliding, a weak freight tape and a Texas verdict overhang remain, and the share-selling pressure from arbitrageurs could last more than a session. Market cap and 20-day average dollar volume are computed from the cited market cap and an average volume of 3.08M shares at about $148.
LW
Scheduled catalyst inside the window: Lamb Weston reports fiscal Q1 2027 results before the open on Oct 6, with a 9:00 AM ET call. Consensus EPS is about $0.58 to $0.59 on revenue of about $1.65B to $1.66B, down from $0.74 a year ago, so the bar is low. Last quarter Lamb Weston beat EPS ($0.87 vs $0.63) and issued FY27 EPS guidance of $2.95 to $3.25. The stock fell about 20% from its August high to about $41 before bouncing 5.9% to $43.60 on Oct 2, so some relief is priced in. Thesis: a beat-and-hold outcome could lift the stock by several percent given short interest of about 4% to 5% of float. Expected move: +4%. Risks: the pre-print rally already priced in some good news, guidance could be trimmed, potato costs and international weakness could surprise, and a miss would hit hard given the stock's weakness. The $43.60 price is the Oct 2 regular-session close. A live Oct 5 quote was not found. Market cap is about $6.0B (as of Oct 2) and the dollar volume is the roughly 1.72M-share average volume times $43.60.
PENG
Penguin Solutions is confirmed to report fiscal Q3-style results after the close on Oct 6, which falls after this window ends, so this is an anticipation trade. Consensus EPS is about $0.77 on revenue of about $519M. The stock closed Oct 2 at $61.36 (up 11.6%) and was about $60.98 premarket Oct 5. A Rosenblatt note cited in a premarket movers list expects a beat-and-raise, and the company beat badly last July (adjusted EPS $0.84 vs $0.56). Options implied about a 17% post-earnings move last time. Thesis: AI-memory enthusiasm and run-up buying continue into the print. Expected move: +2.5%. Risks: the 11.6% Friday surge could mean-revert before the print, the stock is high-beta (about 2.9 to 4.2), margin and dilution concerns exist, and an AI-capex reality check could hit the group. The $61.36 price is the Oct 2 regular-session close. A live Oct 5 quote was not found. Dollar volume is the roughly 2.62M-share average volume times $61.36.
RXO
Observed fact: RXO jumped about 20% premarket on Oct 5 after C.H. Robinson agreed to buy it for $17.25 cash plus 0.0856 CHRW shares per share. With CHRW near $148 the implied value is about $29.94, and RXO was quoted around $28.80, leaving a spread of roughly 4%. Thesis: this is the same theme as the CHRW pick, in that a CHRW rebound lifts RXO's implied value, and the spread should narrow if CHRW stabilises. Expected move: +1.5%. Risks: RXO falls with CHRW if the acquirer keeps sliding, antitrust or financing risk could widen the spread, and the stock already gapped higher. The $28.80 price is a premarket quote (8:13 AM ET) and may be stale. The market cap is the pre-deal figure and understates the current size. Dollar volume is the roughly 2.16M-share average volume (from a MarketBeat report) times $28.80, and the stock cleared the $5 price, $1B market cap and $20M volume floors.
INTC
Observed fact: Intel fell about 4% premarket on Oct 5 (to about $114.5) after Elon Musk confirmed on Oct 4 that TSMC is in talks to join his Terafab chip project, where Intel's 14A node was the only named process. Musk called it just discussions and said something may come of it. An analyst note also flagged Intel's lost PC CPU model share (about 76% on desktops, the lowest since 2023). Thesis: the stock ran from about $33 to a high of about $142, so it is crowded and vulnerable to follow-through selling if TSMC confirms terms or other headlines land, and the broader AI-capex jitters could add pressure. Expected move: -2% from the current price. Risks: the move so far could be an overreaction to unconfirmed talks and rebound sharply, a Terafab announcement naming Intel could squeeze shorts, and the stock is highly volatile. The market cap (about 5.026B shares times $114.52) and dollar volume (about 125.9M-share average volume times $114.52) are derived, not directly reported, so treat them as approximate.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| GPT-5.6 Sol | PCVX, RXO, VST, INTC, DKNG | -2.30% | 40% |
| Perplexity | PCVX, WDC, STX, SYNA, STZ | -2.86% | 40% |
| Grok 4.5 | LW, RPM, STZ, PENG, PTC | -4.40% | 0% |
| Muse Spark 1.1 | PENG, LW, RPM, STZ, PEP | -4.53% | 0% |
| Gemini 1.5 Pro | CHRW, PTC, VST, MOS, LW | +3.58% | 60% |
| DeepSeek | STZ, PEP, DAL, APLD, LW | +2.68% | 80% |
Written up on ForecastNest Insights: Event Gaps: Claude Sonnet 5.5's picks for 2026-10-05.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.